from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3363c/-

LFCtreatmentdescriptionclass of inhibitor

2.314

Amikacinug/mL Amikacintranslation

1.329

Cap5-10ug/mL Capreomycintranslation

3.667

Rox10-50 ug/mL Roxithromycintranslation

0.744

SM2-5 ug/mL Streptomycintranslation

3.871

Tet5-10 ug/mL Tetracyclinetranslation

-0.519

Rif0.2-5ug/mL Rifampicintranscription

0.322

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.577

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.511

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.235

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.579

Clofazimine10-13 ug/mL Clofaziminerespiration

0.164

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.076

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.659

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.668

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.013

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.174

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.514

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.402

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.028

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.689

KCN5-20 ug/mL Potassium cyaniderespiration

-0.421

NaN30.2-2 mM Sodium aziderespiration

1.289

Nigericin50 uM Nigericinrespiration

-0.718

TRC10-150 ug/mL Triclosanrespiration

-0.658

TRZ10-25 ug/mL Thioridazinerespiration

0.281

Valinomycin0.5-10 uM Valinomycinrespiration

0.971

ZnSO42 mM ZnSO4respiration

0.179

menadione6-10 ug/mL Menadionerespiration

-0.103

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.640

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.065

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.781

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.949

NRP_1Non-replicating persistence stage 1dosRassociated

0.639

Amp0.2mg/mL AmpicillincellWall

0.428

Cephalexin20-100 ug/mL CephalexincellWall

0.558

Cerulenin0.32-5 ug/mL CerulenincellWall

0.002

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.243

EMB10-20 ug/mL EthambutolcellWall

0.337

Eta12-40 ug/mL EthionamidecellWall

0.792

INH0.2-0.4 ug/mL IsoniazidcellWall

0.201

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.579

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.396

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.600

BZA0.12 mg/mL BenzamidearomaticAmides

-0.855

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.593

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.413

H2O24 mM hydrogen peroxideDNAdamaging

0.465

Levo10 ug/mL LevofloxacinDNAdamaging

0.512

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.062

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.225

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.627

UVUV-irradiationDNAdamaging

0.466

ARP41-4 ug/mL Antitubercular compound ARP4?

0.459

Antimycin12.5-50 ug/mL Antimycin A?

0.469

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.261

PA_110-50 ug/mL Antitubercular compound PA-1?

0.048

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.657

PA8240.2-2 ug/mL PA-824?

-1.606

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.330

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.368

Verapamil50 uM Verapamil?

0.254

mercaptoethanol2 mM 2-Mercaptoethanol?

0.674

methoxatin10-20 ug/mL Methoxatin?